Literature DB >> 8198991

Selective toxicity of TGF-alpha-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF.

J Kirk1, J Carmichael, I J Stratford, A L Harris.   

Abstract

The sensitivity of human breast and lung cancer cell lines to TGF-alpha-PE40, a novel chimeric recombinant cytotoxin composed of two independent domains, (i) TGF-alpha and (ii) a 40 kDa segment of the Pseudomonas exotoxin protein, PE-40, was investigated. Toxicity varied widely, correlated with epidermal growth factor receptor (EGFR) levels (P = 0.01) and was greatly reduced by EGF, indicating that binding of TGF-alpha-PE40 to EGFR is important in mediating toxicity. Cell lines expressing low EGFR levels were most highly protected by EGF, indicating that normal (low EGFR-expressing) tissue may be selectively protected by EGF in vivo. P-glycoprotein did not confer resistance to TGF-alpha-PE40, and toxicity was unaffected by multidrug resistance-modulating agents (cyclosporin A, tamoxifen, verapamil), indicating a role for TGF-alpha-PE40 in the clinical management of drug-resistant tumours.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198991      PMCID: PMC1969441          DOI: 10.1038/bjc.1994.194

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  The epidermal growth factor receptor and the prognosis of bladder cancer.

Authors:  D E Neal; L Sharples; K Smith; J Fennelly; R R Hall; A L Harris
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

2.  Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay.

Authors:  J A Plumb; R Milroy; S B Kaye
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

3.  Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells.

Authors:  O Kaplan; J W Jaroszewski; P J Faustino; G Zugmaier; B W Ennis; M Lippman; J S Cohen
Journal:  J Biol Chem       Date:  1990-08-15       Impact factor: 5.157

4.  Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.

Authors:  F Baas; A P Jongsma; H J Broxterman; R J Arceci; D Housman; G L Scheffer; A Riethorst; M van Groenigen; A W Nieuwint; H Joenje
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

5.  Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

Authors:  S Nicholson; J R Sainsbury; G K Needham; P Chambers; J R Farndon; A L Harris
Journal:  Int J Cancer       Date:  1988-07-15       Impact factor: 7.396

6.  Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors.

Authors:  K Smith; J A Fennelly; D E Neal; R R Hall; A L Harris
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

Review 7.  Pseudomonas exotoxin: chimeric toxins.

Authors:  I Pastan; D FitzGerald
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.486

8.  Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line.

Authors:  P R Twentyman; N E Fox; D J White
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

9.  Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.

Authors:  S Nicholson; J Richard; C Sainsbury; P Halcrow; P Kelly; B Angus; C Wright; J Henry; J R Farndon; A L Harris
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

10.  Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach.

Authors:  S Ozawa; M Ueda; N Ando; O Abe; N Shimizu
Journal:  Jpn J Cancer Res       Date:  1988-11
View more
  5 in total

Review 1.  The epidermal growth factor receptor in breast cancer.

Authors:  S B Fox; A L Harris
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  Prognostic value of epidermal growth factor expression in breast cancer.

Authors:  R Pirinen; P Lipponen; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.

Authors:  Shaowei Zhu; Yuanyi Liu; Paul C Wang; Xinbin Gu; Liang Shan
Journal:  Biomed Res Int       Date:  2017-06-29       Impact factor: 3.411

4.  Theranostic Gold Nanoantennas for Simultaneous Multiplexed Raman Imaging of Immunomarkers and Photothermal Therapy.

Authors:  Joseph A Webb; Yu-Chuan Ou; Shannon Faley; Eden P Paul; Joseph P Hittinger; Camden C Cutright; Eugene C Lin; Leon M Bellan; Rizia Bardhan
Journal:  ACS Omega       Date:  2017-07-13

5.  EGFR-targeted Chimeras of Pseudomonas ToxA released into the extracellular milieu by attenuated Salmonella selectively kill tumor cells.

Authors:  David Quintero; Jamie Carrafa; Lena Vincent; David Bermudes
Journal:  Biotechnol Bioeng       Date:  2016-07-08       Impact factor: 4.395

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.